메뉴 건너뛰기




Volumn 35, Issue 2, 2013, Pages 122-127

Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions

Author keywords

Hazard function; Interval censoring; Numerical optimization; Piecewise constant; Survival function

Indexed keywords

ARTICLE; HAZARD ASSESSMENT; METHODOLOGY; STATISTICAL ANALYSIS; SURVIVAL;

EID: 84879805523     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.04.009     Document Type: Article
Times cited : (8)

References (11)
  • 1
    • 0020148708 scopus 로고
    • On testing for a constant hazard against a change-point alternative
    • Matthews D.E., Farewell V.T. On testing for a constant hazard against a change-point alternative. Biometrics 1982, 38:463-468.
    • (1982) Biometrics , vol.38 , pp. 463-468
    • Matthews, D.E.1    Farewell, V.T.2
  • 2
    • 0000463918 scopus 로고
    • Inference for a hazard rate change point
    • Loader C.R. Inference for a hazard rate change point. Biometrika 1991, 78:749-757.
    • (1991) Biometrika , vol.78 , pp. 749-757
    • Loader, C.R.1
  • 3
    • 79960892854 scopus 로고    scopus 로고
    • Detecting multiple change points in piecewise constant hazard functions
    • Goodman M.S., Li Y., Tiwari R.C. Detecting multiple change points in piecewise constant hazard functions. J Appl Stat 2011, 38:2523-2532.
    • (2011) J Appl Stat , vol.38 , pp. 2523-2532
    • Goodman, M.S.1    Li, Y.2    Tiwari, R.C.3
  • 4
    • 79960889392 scopus 로고    scopus 로고
    • A hybrid approach to predicting events in clinical trials with time-to-event outcomes
    • Fang L., Su Z. A hybrid approach to predicting events in clinical trials with time-to-event outcomes. Contemp Clin Trials 2011, 32:755-759.
    • (2011) Contemp Clin Trials , vol.32 , pp. 755-759
    • Fang, L.1    Su, Z.2
  • 5
    • 84855358672 scopus 로고    scopus 로고
    • Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: a resampling approach
    • Yi J., Fang L., Su Z. Hybridization of conditional and predictive power for futility assessment in sequential clinical trials with time-to-event outcomes: a resampling approach. Contemp Clin Trials 2012, 22:138-142.
    • (2012) Contemp Clin Trials , vol.22 , pp. 138-142
    • Yi, J.1    Fang, L.2    Su, Z.3
  • 6
    • 0001758946 scopus 로고
    • A problem with the likelihood ratio test for a change-point hazard rate model
    • Henderson R. A problem with the likelihood ratio test for a change-point hazard rate model. Biometrika 1990, 77:835-843.
    • (1990) Biometrika , vol.77 , pp. 835-843
    • Henderson, R.1
  • 7
    • 70350340432 scopus 로고
    • Maximum likelihood estimation in hazard rate models with a change-point
    • Yao Y.C. Maximum likelihood estimation in hazard rate models with a change-point. Commun Stat - Theory Methods 1986, 15:2455-2466.
    • (1986) Commun Stat - Theory Methods , vol.15 , pp. 2455-2466
    • Yao, Y.C.1
  • 8
    • 0020343311 scopus 로고
    • Maximally selected chi-square statistics
    • Miller R.G., Siegmund D. Maximally selected chi-square statistics. Biometrics 1982, 38:1011-1016.
    • (1982) Biometrics , vol.38 , pp. 1011-1016
    • Miller, R.G.1    Siegmund, D.2
  • 9
    • 0000238336 scopus 로고
    • A simplex method for function minimization
    • Nelder J.A., Mead R. A simplex method for function minimization. Comput J 1965, 7:308-313.
    • (1965) Comput J , vol.7 , pp. 308-313
    • Nelder, J.A.1    Mead, R.2
  • 10
    • 39049127861 scopus 로고    scopus 로고
    • An optimization algorithm for designing phase I cancer clinical trials
    • Jiang H., Liu Y.F., Su Z. An optimization algorithm for designing phase I cancer clinical trials. Contemp Clin Trials 2008, 29:102-108.
    • (2008) Contemp Clin Trials , vol.29 , pp. 102-108
    • Jiang, H.1    Liu, Y.F.2    Su, Z.3
  • 11
    • 84864819808 scopus 로고    scopus 로고
    • Optimal allocation of prognostic factors in randomized pre-clinical animal studies
    • Su Z. Optimal allocation of prognostic factors in randomized pre-clinical animal studies. Drug Inf J 2011, 45:725-729.
    • (2011) Drug Inf J , vol.45 , pp. 725-729
    • Su, Z.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.